Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kuca (Otwock, Poland). Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer.. 4265

Member's Comments

No comment yet.

Related content which might interest you: Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 The incidence of serious venous thromboembolic events in 1157 lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Venous thromboembolism and pulmonary cancer: A ten years series Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 The course of chronic thromboembolic pulmonary hypertension (CTEPH) in anticoagulated patients not eligible for pulmonary endarterectomy Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Clinical implications of incidental venous thromboembolism in cancer patients Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019 Year: 2020 Coronary artery disease and lung cancer surgery Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012